Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism

This publication has 10 references indexed in Scilit:

• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
  Published by Elsevier ,2004
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Neurology: Predicting Parkinson's disease
  Nature, 1985
• Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Biochemical and Biophysical Research Communications, 1985
• Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP
  Biochemical and Biophysical Research Communications, 1984
• 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra
  Neuroscience Letters, 1984
• AETIOLOGY OF PARKINSON'S DISEASE
  The Lancet, 1983
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Studies on the Respiratory Chain-linked Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase
  Published by Elsevier ,1970
• Kinetic Studies on Reduced Diphosphopyridine Nucleotide Dehydrogenase by Electron Paramagnetic Resonance Spectroscopy
  Published by Elsevier ,1965